One-health pathogens in the Aspergillus viridinutans complex

Jessica J Talbot1, Vanessa R Barrs1

  • 1The University of Sydney, NSW 2006 Australia, Faculty of Veterinary Science, School of Life and Environmental Sciences.

Medical Mycology
|April 6, 2017
PubMed

Insights

The Aspergillus viridinutans complex (AVC) comprises emerging fungal pathogens causing chronic and difficult-to-treat infections in humans and animals. Understanding AVC species is crucial for effective one-health management strategies.

Area of Science:

  • Mycology
  • Infectious Diseases
  • One Health

Background:

  • Cryptic species within Aspergillus section Fumigati are recognized as significant pathogens in both human and animal health.
  • The Aspergillus viridinutans complex (AVC) has expanded to include 10 species, with six identified as pathogenic.
  • These pathogenic AVC species cause severe invasive syndromes, including chronic pulmonary aspergillosis in humans and disseminated infections in companion animals.

Purpose of the Study:

  • To review the history, phylogenetic relationships, and characteristics of the Aspergillus viridinutans complex.
  • To explore the environmental distribution, secondary metabolite production, and clinical significance of AVC species.
  • To provide insights into the antifungal susceptibility patterns of AVC, relevant for one-health practitioners.

Main Methods:

  • Phylogenetic analysis to delineate species within the AVC.
  • Review of existing literature on clinical cases and environmental isolates.
  • Antifungal susceptibility testing to determine minimum inhibitory concentrations (MICs).

Main Results:

  • The AVC includes six pathogenic species causing invasive diseases in humans, cats, and dogs.
  • AVC infections are often chronic and less responsive to antifungal therapy compared to Aspergillus fumigatus.
  • Higher MICs of antifungal drugs are characteristic of AVC species.

Conclusions:

  • The Aspergillus viridinutans complex represents a growing threat in both human and veterinary medicine.
  • Effective management requires a comprehensive understanding of AVC's phylogeny, clinical impact, and drug resistance.
  • This review highlights the importance of a one-health approach for addressing infections caused by these emerging fungal pathogens.

Related Concept Videos

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
Fungal Phylum Basidiomycota01:26

Fungal Phylum Basidiomycota

Basidiomycota is a diverse phylum of fungi that includes ecologically significant decomposers such as white rot fungi, symbionts like mycorrhizal fungi, plant pathogens such as rusts and smuts, and edible species like Agaricus bisporus (the common button mushroom). These fungi play crucial roles in nutrient cycling, symbiotic relationships, and even human health. Their defining feature is the basidium, a microscopic club-shaped structure responsible for producing basidiospores.Fruiting Bodies...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...